Article ; Online: Potential new treatment strategies for COVID-19: is there a role for bromhexine as add-on therapy?
Internal and emergency medicine
2020 Volume 15, Issue 5, Page(s) 801–812
Abstract: Of huge importance now is to provide a fast, cost-effective, safe, and immediately available pharmaceutical solution to curb the rapid global spread of SARS-CoV-2. Recent publications on SARS-CoV-2 have brought attention to the possible benefit of ... ...
Abstract | Of huge importance now is to provide a fast, cost-effective, safe, and immediately available pharmaceutical solution to curb the rapid global spread of SARS-CoV-2. Recent publications on SARS-CoV-2 have brought attention to the possible benefit of chloroquine in the treatment of patients infected by SARS-CoV-2. Whether chloroquine can treat SARS-CoV-2 alone and also work as a prophylactic is doubtful. An effective prophylactic medication to prevent viral entry has to contain, at least, either a protease inhibitor or a competitive virus ACE2-binding inhibitor. Using bromhexine at a dosage that selectively inhibits TMPRSS2 and, in so doing, inhibits TMPRSS2-specific viral entry is likely to be effective against SARS-CoV-2. We propose the use of bromhexine as a prophylactic and treatment. We encourage the scientific community to assess bromhexine clinically as a prophylactic and curative treatment. If proven to be effective, this would allow a rapid, accessible, and cost-effective application worldwide. |
---|---|
MeSH term(s) | Betacoronavirus ; Bromhexine/therapeutic use ; COVID-19 ; Coronavirus Infections/drug therapy ; Expectorants/therapeutic use ; Humans ; Pandemics ; Pneumonia, Viral/drug therapy ; SARS-CoV-2 ; Serine Endopeptidases/drug effects ; Virus Internalization/drug effects |
Chemical Substances | Expectorants ; Serine Endopeptidases (EC 3.4.21.-) ; TMPRSS2 protein, human (EC 3.4.21.-) ; Bromhexine (Q1J152VB1P) |
Keywords | covid19 |
Language | English |
Publishing date | 2020-05-26 |
Publishing country | Italy |
Document type | Journal Article ; Review |
ZDB-ID | 2454173-4 |
ISSN | 1970-9366 ; 1828-0447 |
ISSN (online) | 1970-9366 |
ISSN | 1828-0447 |
DOI | 10.1007/s11739-020-02383-3 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
Full text online
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
Zs.A 6673: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.